PRESCIENT NEUROPHARMA INC. ANNOUNCES STOCK OPTION GRANT

Show Health and Fitness Publications

Fri, November 12, 2010

[ Fri, Nov 12th 2010 ] - Market Wire

Medtronic to Announce Financial Results for the Second Quarter of Fiscal Year 2011

[ Fri, Nov 12th 2010 ] - Market Wire

Derma Sciences Reports Third Quarter Net Sales Up 17%, Advanced Wound Care Sales Up 38%

[ Fri, Nov 12th 2010 ] - Market Wire

Cerus to Present at the Stephens Fall Investment Conference

[ Fri, Nov 12th 2010 ] - Market Wire

Cerus to Present at the Lazard Capital Markets 7th Annual Healthcare Conference

[ Fri, Nov 12th 2010 ] - Market Wire

BioDelivery Sciences to Hold Investor Conference Call on Monday, November 15, 2010

[ Fri, Nov 12th 2010 ] - Market Wire

POZEN Announces Achievement of $25 Million Milestone For VIMOVOa"

[ Fri, Nov 12th 2010 ] - Market Wire

Pro-Pharmaceuticals Reports Third Quarter 2010 and Nine Months Financial Results

[ Fri, Nov 12th 2010 ] - Market Wire

LABOPHARM RECEIVES NOTICE OF ANDA SUBMISSION WITH .. H IV CERTIFICATION FOR GENERIC OF OLEPTRO&;#8482;

[ Fri, Nov 12th 2010 ] - Market Wire

Somaxon Pharmaceuticals to Present at Lazard Capital Markets 7th Annual Healthcare Conference

[ Fri, Nov 12th 2010 ] - Market Wire

Medical Facilities Corporation Reports Third Quarter 2010 Results

[ Fri, Nov 12th 2010 ] - Market Wire

Chairman and CEO of Spectral Molecular Imaging De .. ging and Operating Rooms of the Future at an Inte

Thu, November 11, 2010

[ Thu, Nov 11th 2010 ] - Market Wire

Baxter to Present at the Piper Jaffray a" 22nd Annual Health Care Conference

[ Thu, Nov 11th 2010 ] - Market Wire

CENTRIC HEALTH REPORTS 49% INCREASE IN NET INCOME FOR Q3 2010

[ Thu, Nov 11th 2010 ] - Market Wire

Forest Laboratories Enters Collaboration on Bystolic® and Savella® in Canada

[ Thu, Nov 11th 2010 ] - Market Wire

Array BioPharma to Present at the Lazard Capital Markets 7th Annual Healthcare Conference

[ Thu, Nov 11th 2010 ] - Market Wire

Alnylam Pharmaceuticals, Roche, Novartis, Cubist Pharmaceuticals and Biogen Idec

[ Thu, Nov 11th 2010 ] - Market Wire

Covidien plc, Johnson & Johnson, Becton Dickinson, C.R. Bard and Atmel Corporation

[ Thu, Nov 11th 2010 ] - Market Wire

Biogen Idec, Greatbatch, Macya?s, Jamba and Gentiva Health Services

[ Thu, Nov 11th 2010 ] - Market Wire

Zacks Releases Four Powerful ''Buy'' Stocks: Osir .. , Bancolombia, JAKKS Pacific and ReneSola Limited

[ Thu, Nov 11th 2010 ] - Market Wire

Corgenix Reports First Quarter Fiscal 2011 Financial Results

[ Thu, Nov 11th 2010 ] - Market Wire

DUSA Pharmaceuticals to Present at the 4th Annual Maxim Group Growth Conference

[ Thu, Nov 11th 2010 ] - Market Wire

Roche Diagnostics Signs Memorandum of Understanding for a Strategic Partnership with CapitalBio

[ Thu, Nov 11th 2010 ] - Market Wire

Geron Announces Two Publications Demonstrating Th .. lomerase Inhibitor Drug Targets Cancer Stem Cells

[ Thu, Nov 11th 2010 ] - Market Wire

GTx Announces Corporate Presentation at the Lazard Capital Markets Annual Healthcare Conference

[ Thu, Nov 11th 2010 ] - Market Wire

Ceregene Raises $11.5 Million in Series D Financing

[ Thu, Nov 11th 2010 ] - Market Wire

Gallup and Healthways Release October 2010 U.S. Well-Being Report

[ Thu, Nov 11th 2010 ] - Market Wire

Health Management Associates, Inc. to Present at .. 0 Bank of America Merrill Lynch Credit Conference

Wed, November 10, 2010

[ Wed, Nov 10th 2010 ] - Market Wire

ArQule, Inc. to Present at Lazard Capital Markets 7th Annual Healthcare Conference

[ Wed, Nov 10th 2010 ] - Market Wire

Abiomed to Present at Lazard Capital Markets 7th Annual Healthcare Conference

[ Wed, Nov 10th 2010 ] - Market Wire

Enzo Biochem to Present at Lazard Capital Markets 7th Annual Healthcare Conference

[ Wed, Nov 10th 2010 ] - Market Wire

MannKind to Present at the Lazard Capital Markets 7th Annual Healthcare Conference

[ Wed, Nov 10th 2010 ] - Market Wire

Neoprobe Announces Third Quarter 2010 Results

[ Wed, Nov 10th 2010 ] - Market Wire

BELLUS HEALTH REPORTS RESULTS FOR THIRD QUARTER E .. NNOUNCES RECEIPT OF US$5 MILLION FROM PARTNER CEL

[ Wed, Nov 10th 2010 ] - Market Wire

Forest Laboratories, Inc. Announces Executive Man .. ment of Lawrence Olanoff as President and Chief O

[ Wed, Nov 10th 2010 ] - Market Wire

Incyte to Host Webcast at 2010 ACR/ARHP Annual Scientific Meeting

[ Wed, Nov 10th 2010 ] - Market Wire

ARIAD to Present at the Lazard Capital Markets 7th Annual Healthcare Conference

[ Wed, Nov 10th 2010 ] - Market Wire

Oncolytics Biotech® Inc. Announces Third Quarter 2010 Results

[ Wed, Nov 10th 2010 ] - Market Wire

Zalicus Reports Financial Results for the Third Quarter 2010

[ Wed, Nov 10th 2010 ] - Market Wire

Spectranetics to Present at the Citi Small/Mid Cap Conference on November 17

[ Wed, Nov 10th 2010 ] - Market Wire

AngioDynamics to Participate at the Stephens Inc. Fall Investment Conference

[ Wed, Nov 10th 2010 ] - Market Wire

AVEO to Present New Clinical Data Evaluating Tivo .. bination with FOLFOX6 at EORTC-NCI-AACR Symposium

[ Wed, Nov 10th 2010 ] - Market Wire

Cerus Corporation Prices Public Offering of Common Stock and Warrants

Tue, November 9, 2010

[ Tue, Nov 09th 2010 ] - Market Wire

IntegraMed® To Participate At The Lazard Capital .. s 7th Annual Healthcare Conference On November 16

[ Tue, Nov 09th 2010 ] - Market Wire

CENTRIC HEALTH RECEIVES FINANCING FROM MAJOR SHAREHOLDER FOR MERGERS &; ACQUISITIONS

[ Tue, Nov 09th 2010 ] - Market Wire

Illumina to Present at Upcoming Investment Conferences in November

[ Tue, Nov 09th 2010 ] - Market Wire

SuperGen to Present at Lazard Healthcare Conference on November 16th

[ Tue, Nov 09th 2010 ] - Market Wire

NeuroMetrix Reports Q3 2010 Financial Results Pro .. ss in New Sales Channel; Reduced Cash Consumption

[ Tue, Nov 09th 2010 ] - Market Wire

Diabetes Especially Serious for Seniors

[ Tue, Nov 09th 2010 ] - Market Wire

Biovista Announces a Drug Repositioning Collaboration With Pfizer

[ Tue, Nov 09th 2010 ] - Market Wire

U.S. FDA Grants Fast-Track Designation to Sanofi .. r's Investigational Clostridium difficile Vaccine

[ Tue, Nov 09th 2010 ] - Market Wire

LifeVantage Announces Unaudited First Quarter Fiscal 2011 Financial and Operating Results

[ Tue, Nov 09th 2010 ] - Market Wire

MabCure Generates Tumor Specific Antibodies again .. d Lead to a Blood/Urine Diagnostic Test for Prost

[ Tue, Nov 09th 2010 ] - Market Wire

Neoprobe 3rd Quarter Business Update Conference Call Invitation

[ Tue, Nov 09th 2010 ] - Market Wire

CompCare to Report 2010 Third Quarter Financial Results on November 15, 2010

[ Tue, Nov 09th 2010 ] - Market Wire

Seattle Genetics and Millennium to Present Brentu .. cal Data at American Society of Hematology Annual

[ Tue, Nov 09th 2010 ] - Market Wire

Vertex Pharmaceuticals Announces Webcast of its P .. at the Credit Suisse Annual Healthcare Conference

[ Tue, Nov 09th 2010 ] - Market Wire

Analysis Shows Topical NSAID Has Potentially Bett .. ofile Than Oral NSAIDs in Treatment of Knee Osteo

Mon, November 8, 2010

[ Mon, Nov 08th 2010 ] - Market Wire

Anika Therapeutics Reports 29% Total Revenue Growth in Third Quarter 2010

[ Mon, Nov 08th 2010 ] - Market Wire

Charles River to Present at Credit Suisse Healthcare Conference

[ Mon, Nov 08th 2010 ] - Market Wire

AGA Medical Reports 2010 Third Quarter Financial Results

[ Mon, Nov 08th 2010 ] - Market Wire

Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2011

[ Mon, Nov 08th 2010 ] - Market Wire

Emeritus Corporation Announces Common Stock Offering

[ Mon, Nov 08th 2010 ] - Market Wire

Clinical Data, Inc. Launches FAMILION® Genetic T .. ompaction and Long QT Syndrome Large Deletion/Dup

[ Mon, Nov 08th 2010 ] - Market Wire

CPEX Pharmaceuticals Reports Third-Quarter 2010 Financial Results

[ Mon, Nov 08th 2010 ] - Market Wire

Progenics Pharmaceuticals Announces Third Quarter 2010 Financial Results

[ Mon, Nov 08th 2010 ] - Market Wire

Transdel Pharmaceuticals Reports Third Quarter and Year-to-Date 2010 Results

[ Mon, Nov 08th 2010 ] - Market Wire

IsoRay Awarded More Than $526,000 in Federal Grants for Breast, Brain and Lung Cancer

[ Mon, Nov 08th 2010 ] - Market Wire

Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences

[ Mon, Nov 08th 2010 ] - Market Wire

GTx Appoints Dr. Barry Furr to the Board of Directors

[ Mon, Nov 08th 2010 ] - Market Wire

BioCryst to Present New Data for BCX4208 Monother .. an College of Rheumatology (ACR) Scientific Meeti

[ Mon, Nov 08th 2010 ] - Market Wire

Community Health Systems, Inc. Announces Amendment and Extension of Credit Agreement

[ Mon, Nov 08th 2010 ] - Market Wire

China Kanghui Holdings Announces Board of Director Changes

Sun, November 7, 2010

[ Sun, Nov 07th 2010 ] - Market Wire

Santarus Announces Positive Top-Line Results in E .. y Evaluating Budesonide MMX in Ulcerative Colitis

Sat, November 6, 2010

[ Sat, Nov 06th 2010 ] - Market Wire

GlaxoSmithKline and XenoPort Respond to FDA on Horizanta" for RLS

[ Sat, Nov 06th 2010 ] - Market Wire

XenoPort Announces New Employment Inducement Award

Fri, November 5, 2010

[ Fri, Nov 05th 2010 ] - Market Wire

Alkermesa? Corporate Presentation to be Webcast at the Credit Suisse Healthcare Conference

[ Fri, Nov 05th 2010 ] - Market Wire

Heightened Interest from the Medical Research Com .. ernational Stem Cell Corporationa?s (ISCO) Therap

[ Fri, Nov 05th 2010 ] - Market Wire

Osiris Therapeutics Reports Third Quarter 2010 Financial Results

[ Fri, Nov 05th 2010 ] - Market Wire

Dr. Paul Berg to Retire from Gilead Sciencesa? Board of Directors

[ Fri, Nov 05th 2010 ] - Market Wire

Positron Announces Completion of Cardio-Assista"; Set for Early 2011 Deployment

[ Fri, Nov 05th 2010 ] - Market Wire

Exact Sciences Prices Public Offering of Common Stock

[ Fri, Nov 05th 2010 ] - Market Wire

CORRECTING and REPLACING Response Genetics, Inc. Reports Third Quarter 2010 Financial Results

[ Fri, Nov 05th 2010 ] - Market Wire

ZIOPHARM Reports Third Quarter Financial Results and Updates Clinical Programs

[ Fri, Nov 05th 2010 ] - Market Wire

Orthovita to Present at the Maxim Group 4th Annual Growth Conference

[ Fri, Nov 05th 2010 ] - Market Wire

Alnylam Grants New InterfeRxTM Intellectual Prope .. evelopment and Commercialization of TKM-Ebola, an

[ Fri, Nov 05th 2010 ] - Market Wire

ARCA biopharma Awarded $489,000 Grant under Qualifying Therapeutic Discovery Project

[ Fri, Nov 05th 2010 ] - Market Wire

Emergent BioSolutions Receives Orphan Drug Design .. Monoclonal Antibody for the Treatment of Inhalat

[ Fri, Nov 05th 2010 ] - Market Wire

Synta Pharmaceuticals Reports Third-Quarter 2010 Financial Results and Clinical Update

[ Fri, Nov 05th 2010 ] - Market Wire

Abiomed Reports Record Revenues of $23.4 Million, up 17% for Second Quarter of Fiscal 2011

[ Fri, Nov 05th 2010 ] - Market Wire

Columbia Laboratories Reports Third Quarter 2010 Financial Results

Thu, November 4, 2010

[ Thu, Nov 04th 2010 ] - Market Wire

PRESCIENT NEUROPHARMA INC. ANNOUNCES STOCK OPTION GRANT

[ Thu, Nov 04th 2010 ] - Market Wire

Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2010

[ Thu, Nov 04th 2010 ] - Market Wire

Exelixis Announces Third Quarter 2010 Financial Results

[ Thu, Nov 04th 2010 ] - Market Wire

Targacept Reports Third Quarter 2010 Financial Results

[ Thu, Nov 04th 2010 ] - Market Wire

Obagi Medical Products' Third Quarter 2010 Net Sales Rise 12 Percent

[ Thu, Nov 04th 2010 ] - Market Wire

Alkermes Reports Second Quarter Fiscal 2011 Financial Results

[ Thu, Nov 04th 2010 ] - Market Wire

RehabCare to Present at the Stephens Fall Investor Conference 2010

[ Thu, Nov 04th 2010 ] - Market Wire

GenMark Reports Third Quarter Results

[ Thu, Nov 04th 2010 ] - Market Wire

InSite Vision Reports Third Quarter 2010 Financial Results

[ Thu, Nov 04th 2010 ] - Market Wire

Chesley Files Class Action Against DePuy Orthopaedics

[ Thu, Nov 04th 2010 ] - Market Wire

Nasdaq Panel Grants American Learning Corporationa?s Request for Continued Listing

[ Thu, Nov 04th 2010 ] - Market Wire

El Senado de California proclama la semana del 7 .. 3 de noviembre como Semana Educativa sobre la CKD

[ Thu, Nov 04th 2010 ] - Market Wire

Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference

[ Thu, Nov 04th 2010 ] - Market Wire

Medtronic Marks Bladder Health Awareness Month with National Womena?s Health Campaign

[ Thu, Nov 04th 2010 ] - Market Wire

Chemed Corporation to Present at the 2010 Annual Credit Suisse Healthcare Conference

Wed, November 3, 2010

[ Wed, Nov 03rd 2010 ] - Market Wire

Kahn Swick & Foti, LLC and Former Louisiana State .. stors With Large Financial Interests (Over $100,0

[ Wed, Nov 03rd 2010 ] - Market Wire

La vacuna contra el dengue de Sanofi Pasteur est en fase final de desarrollo clnico

[ Wed, Nov 03rd 2010 ] - Market Wire

Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development

[ Wed, Nov 03rd 2010 ] - Market Wire

SurModics and Edge Therapeutics Collaborate on De .. lopment of Sustained-Release Neurological Product

[ Wed, Nov 03rd 2010 ] - Market Wire

Teleflex to Present at the Credit Suisse 2010 Healthcare Conference

[ Wed, Nov 03rd 2010 ] - Market Wire

Eugene Melnyk Delivers Notice of Appeal in OSC Matter

[ Wed, Nov 03rd 2010 ] - Market Wire

Community Health Systems to Participate in Credit Suisse 2010 Healthcare Conference

[ Wed, Nov 03rd 2010 ] - Market Wire

Illumina Introduces TruSeqa" Sample Prep and Exome Enrichment Kits

[ Wed, Nov 03rd 2010 ] - Market Wire

AVEO Pharmaceuticalsa? Tivozanib Recognized as On .. ndhovera?s 2011 Top 10 Oncology Projects to Watch

[ Wed, Nov 03rd 2010 ] - Market Wire

Fibrocell Science, Inc. Establishes Joint Venture to Market Its Technology Platform in Asia

[ Wed, Nov 03rd 2010 ] - Market Wire

CardioNet, Inc. Announces National Reimbursement Rate for Mobile Cardiovascular Telemetry

[ Wed, Nov 03rd 2010 ] - Market Wire

Orthovita Reports 2010 Third Quarter Financial Results And Updates Full Year Financial Guidance

[ Wed, Nov 03rd 2010 ] - Market Wire

BioCryst Awarded $1.1 Million in Grants for Qualifying Therapeutic Development Projects

[ Wed, Nov 03rd 2010 ] - Market Wire

Curis Awarded $500,000 in Grants Under the Patient Protection and Affordable Care Act

[ Wed, Nov 03rd 2010 ] - Market Wire

TSO3 ANNOUNCES FINANCIAL RESULTS FOR Q3 2010

Tue, November 2, 2010

[ Tue, Nov 02nd 2010 ] - Market Wire

Teva Reports Record Third Quarter 2010 Results

[ Tue, Nov 02nd 2010 ] - Market Wire

Insight Imaging Reports Discussions on Potential Restructuring Plan

[ Tue, Nov 02nd 2010 ] - Market Wire

Los compuestos en fase de investigacin GS 9190 y .. tamiento de la hepatitis C en combinacin con trat

[ Tue, Nov 02nd 2010 ] - Market Wire

Array BioPharma to Report Financial Results for t .. First Quarter of Fiscal 2011 on November 8, 2010

[ Tue, Nov 02nd 2010 ] - Market Wire

GenMark Diagnostics Acquires License to HCV Genotyping Patent Estate

[ Tue, Nov 02nd 2010 ] - Market Wire

SurModics to Webcast Fourth Quarter and Fiscal Year 2010 Earnings Conference Call November 10

[ Tue, Nov 02nd 2010 ] - Market Wire

Corgenix to Host Conference Call to Discuss First Quarter Results

[ Tue, Nov 02nd 2010 ] - Market Wire

Notice of Medical Facilities Corporation';s Fisca .. 0 Third Quarter Financial Results Conference Call

[ Tue, Nov 02nd 2010 ] - Market Wire

WellCare Board Adopts Majority Voting Standard for Director Elections

[ Tue, Nov 02nd 2010 ] - Market Wire

Aeolus Pharmaceuticalsa? AEOL 10150 Promotes Surv .. man Primates Exposed to Lethal Doses of Radiation

[ Tue, Nov 02nd 2010 ] - Market Wire

Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Qua .. er 2010 Financial Results Call Set for November 9

[ Tue, Nov 02nd 2010 ] - Market Wire

Tolerx Forms Scientific Advisory Board to Advance Research in Type 1 Diabetes

[ Tue, Nov 02nd 2010 ] - Market Wire

Coventry Health Care, Expeditors International, A .. source Bergen, Principal Financial and Kellogga?s

[ Tue, Nov 02nd 2010 ] - Market Wire

Neurocrine Biosciences, Jacobs Engineering, Ford, Kellogg and Honda Motor Co.

[ Tue, Nov 02nd 2010 ] - Market Wire

DUSA Pharmaceuticals, Inc.® to Host Third Quarte .. Highlights and Financial Results Conference Call

Mon, November 1, 2010

[ Mon, Nov 01st 2010 ] - Market Wire

Prestige Brands Holdings, Inc. Completes Purchase of Blacksmith Brands

[ Mon, Nov 01st 2010 ] - Market Wire

Biomagnetics Completes Audit and Financial Review

[ Mon, Nov 01st 2010 ] - Market Wire

NeoStem to Present at Cell Therapy Industry Summi .. eld on November 3-5, 2010 in Carlsbad, California

[ Mon, Nov 01st 2010 ] - Market Wire

Clinical Data, Inc. Granted Orphan Drug Designati .. for PRX-8066 for Pulmonary Arterial Hypertension

[ Mon, Nov 01st 2010 ] - Market Wire

Health Management Associates, Inc. to Present at the Oppenheimer 21st Annual Healthcare Conference

[ Mon, Nov 01st 2010 ] - Market Wire

Two Directors Step Down from Elan Board in Accordance with Previously Announced Intention

[ Mon, Nov 01st 2010 ] - Market Wire

I composti sperimentali per l'epatite C di Gilead .. azione con terapie standard di cura ottengono una

[ Mon, Nov 01st 2010 ] - Market Wire

Theragenics to Report Third Quarter 2010 Financial Results Tuesday, November 9

[ Mon, Nov 01st 2010 ] - Market Wire

Orthovita to Present at the Lazard Capital Markets 7th Annual Healthcare Conference

[ Mon, Nov 01st 2010 ] - Market Wire

ARIAD to Webcast Conference Call on Third Quarter 2010 Financial Results

[ Mon, Nov 01st 2010 ] - Market Wire

Hepatitis-C-Prfprparate GS 9190 und GS 9256 von G .. Phase II zusammen mit Standardtherapien wesentli

[ Mon, Nov 01st 2010 ] - Market Wire

American Anesthesiology Announces the Acquisition of Greensboro, NC, Group Practice

[ Mon, Nov 01st 2010 ] - Market Wire

Inhibitex Initiates Phase 1b Multiple Ascending D .. l of INX-189 in Patients with Chronic Hepatitis C

[ Mon, Nov 01st 2010 ] - Market Wire

Medisafe 1 Technologies Appoints Tali Skoczylas as Chair of Medical Advisory Board

[ Mon, Nov 01st 2010 ] - Market Wire

Porex Corporation Divests Surgical Division to Stryker Corporation

Sat, October 30, 2010

[ Sat, Oct 30th 2010 ] - Market Wire

A Celgene anuncia resultados financeiros e operacionais recordes no terceiro trimestre de 2010

[ Sat, Oct 30th 2010 ] - Market Wire

Viread® for Hepatitis B Maintains Antiviral Supp .. ent of Resistance Through Four Years of Treatment

[ Sat, Oct 30th 2010 ] - Market Wire

Gileada?s Investigational Hepatitis C Compounds G .. tion with Standard of Care Therapies Achieve Subs

[ Sat, Oct 30th 2010 ] - Market Wire

Salix Pharmaceuticals Previews Data Slated for Pr .. ting of the American Association for the Study of

[ Sat, Oct 30th 2010 ] - Market Wire

New Data From Phase 3 Studies Showed Superior SVR .. with Telaprevir-Based Combination Therapy in Peop

Fri, October 29, 2010

[ Fri, Oct 29th 2010 ] - Market Wire

Fitch Affirms Boston Scientific's IDR at 'BB+'; Outlook to Positive

[ Fri, Oct 29th 2010 ] - Market Wire

Teva Invites Public to Listen to Its Respiratory Opportunity Meeting Webcast

[ Fri, Oct 29th 2010 ] - Market Wire

Ligand to Report Third Quarter Results on November 9

[ Fri, Oct 29th 2010 ] - Market Wire

St. Jude Medical???2010??????????????

[ Fri, Oct 29th 2010 ] - Market Wire

Celgene meldet rekordverdchtiges Betriebs- und Finanzergebnis fr das dritte Quartal 2010

[ Fri, Oct 29th 2010 ] - Market Wire

Seattle Genetics to Present at Oppenheimer Healthcare Conference

[ Fri, Oct 29th 2010 ] - Market Wire

Sequenom Announces Date of Third Quarter 2010 Financial Results and Conference Call

[ Fri, Oct 29th 2010 ] - Market Wire

Idera Pharmaceuticals Appoints Sudhir Agrawal as .. Directors and William S. Reardon as Lead Director

[ Fri, Oct 29th 2010 ] - Market Wire

Alnylam Scientists to Present New Data on RNAi Th .. Meeting of the American Association for the Stud

[ Fri, Oct 29th 2010 ] - Market Wire

MannKind Corporation Reports 2010 Third Quarter Financial Results

[ Fri, Oct 29th 2010 ] - Market Wire

Abstracts Highlighting Data from Enzona?s mRNA An .. d for Presentation at 2010 EORTC-NCI-AACR Meeting

[ Fri, Oct 29th 2010 ] - Market Wire

Celgene Corporation to Present at Oppenheimera?s 21st Annual Healthcare Conference

[ Fri, Oct 29th 2010 ] - Market Wire

Compugen Licenses Novel Oncology Target to Seattle Genetics

[ Fri, Oct 29th 2010 ] - Market Wire

Magellan Health Services Reports Third Quarter 2010 Financial Results

[ Fri, Oct 29th 2010 ] - Market Wire

Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference

Thu, October 28, 2010

[ Thu, Oct 28th 2010 ] - Market Wire

Urologix to Host Its Fiscal 2011 First Quarter Conference Call

[ Thu, Oct 28th 2010 ] - Market Wire

Exact Sciences Reports Positive Results for Colorectal Cancer Screening Test

[ Thu, Oct 28th 2010 ] - Market Wire

Celgene meldt recordresultaten voor derde kwartaal 2010

[ Thu, Oct 28th 2010 ] - Market Wire

Health Net Expands Mobile Capabilities

[ Thu, Oct 28th 2010 ] - Market Wire

InSite Vision to Report Third Quarter Financial Results on November 4, 2010

[ Thu, Oct 28th 2010 ] - Market Wire

Emeritus Corporation to Host Third Quarter 2010 Earnings Conference Call and Webcast

[ Thu, Oct 28th 2010 ] - Market Wire

ArthroCare Receives FDA Clearance for Spartan PEEK Suture Implant

[ Thu, Oct 28th 2010 ] - Market Wire

Celgene Reports Record Third Quarter 2010 Operating and Financial Results

[ Thu, Oct 28th 2010 ] - Market Wire

Celgene comunica risultati finanziari e operativi record per il terzo trimestre del 2010

[ Thu, Oct 28th 2010 ] - Market Wire

Natus Medical Announces 2010 Third Quarter Financial Results

[ Thu, Oct 28th 2010 ] - Market Wire

Curis Reports Third Quarter 2010 Financial Results

[ Thu, Oct 28th 2010 ] - Market Wire

Pro-Pharmaceuticals Ships First Commercial Order for DAVANAT®

[ Thu, Oct 28th 2010 ] - Market Wire

ACADIA Pharmaceuticals Enters Agreement with Biov .. and Regain North American Rights to Pimavanserin

[ Thu, Oct 28th 2010 ] - Market Wire

BioCryst Reports Third Quarter 2010 Financial Results and Provides Corporate Update

[ Thu, Oct 28th 2010 ] - Market Wire

AngioDynamics Announces Election of Kevin J. Gould to Board of Directors

Wed, October 27, 2010

[ Wed, Oct 27th 2010 ] - Market Wire

Crown Oil and Gas Announces Appointment of Director

[ Wed, Oct 27th 2010 ] - Market Wire

Somaxon Pharmaceuticals to Report Third Quarter 2 .. nd Conduct Conference Call on Tuesday, November 9

[ Wed, Oct 27th 2010 ] - Market Wire

Human Genome Sciences Announces Third Quarter 2010 Financial Results and Key Developments

[ Wed, Oct 27th 2010 ] - Market Wire

Alnylam to Webcast Conference Call Discussing Third Quarter 2010 Financial Results

[ Wed, Oct 27th 2010 ] - Market Wire

Northstar Healthcare Announces Senior Management Changes

[ Wed, Oct 27th 2010 ] - Market Wire

New therapeutisch verband van KCI verbetert kwalteit van de huid en voorkomt decubitus

[ Wed, Oct 27th 2010 ] - Market Wire

Gilead Sciences, Linear Technology, Biogen Idec, Elan and Novartis

[ Wed, Oct 27th 2010 ] - Market Wire

La nueva superficie terap©utica de KCI mejora la .. ara la prevencin y el manejo de lceras por presin

[ Wed, Oct 27th 2010 ] - Market Wire

Neue therapeutische Oberflche von KCI verbessert .. tegritt fr Prvention und Management von Dekubitus

[ Wed, Oct 27th 2010 ] - Market Wire

Nuova superficie terapeutica sviluppata da KCI ri .. la prevenzione e la gestione delle piaghe da dec

[ Wed, Oct 27th 2010 ] - Market Wire

ZIOPHARM Oncology to Present at Oppenheimer 21st Annual Healthcare Conference

[ Wed, Oct 27th 2010 ] - Market Wire

Bond Labsa? Resurrectiona" Conducts In-Store Promotions for Cub Foods®

[ Wed, Oct 27th 2010 ] - Market Wire

ARIAD to Present at the Oppenheimer & Co. 21st Annual Healthcare Conference

[ Wed, Oct 27th 2010 ] - Market Wire

Successful IsoRay Study of Cesium-131 Internal Ra .. Breast CancerPaves the Way for Advanced Treatment

[ Wed, Oct 27th 2010 ] - Market Wire

Exact Sciences Reports Third-Quarter 2010 Financial Results

PRESCIENT NEUROPHARMA INC. ANNOUNCES STOCK OPTION GRANT

_{//health-fitness.news-articles.net/content/2010/ .. europharma-inc-announces-stock-option-grant.html}
^{Published in Health and Fitness on Thursday, November 4th 2010 at 15:50 GMT by Market Wire}

TSXV: PNO

VANCOUVER, Nov. 4 /CNW/ - Prescient Neuropharma Inc. (the "Company") announces that pursuant to the Company's Stock Option Plan, a total of 1,000,000 incentive stock options have been granted to directors and officers, charitable organizations and consultants of the Company. The options are exercisable at a price of $0.13 per share for a period of 10 years, subject to regulatory approval.

ON BEHALF OF THE BOARD OF DIRECTORS

"Gordon Keep"
Per: ____________

Gordon Keep
President & Director

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS
DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire